This article is about three special companies in the health care business that are likely to do well and grow this quarter. These companies are Haemonetics Corporation, Immunitybio Inc, and Progyny Inc. The article says that these companies' stocks have gone down a lot recently, but this could mean they are good bargains to buy now. These companies are making some exciting announcements and their stocks have started to go up again. Read from source...

Avi Kapoor, the author of "Top 3 Health Care Stocks That Are Set To Fly This Quarter," presents three oversold stocks in the health care sector: Haemonetics Corporation (HAE), Immunitybio Inc (IBRX), and Progyny Inc (PGNY). Kapoor uses the Relative Strength Index (RSI) as a momentum indicator to show that these stocks are undervalued. However, the article lacks clear guidelines on how to interpret RSI values and how to use them to make investment decisions. Also, the article does not provide enough information about the companies' financials or the market conditions that could affect their performance. Furthermore, the article's title is misleading because it implies that the stocks are set to fly this quarter, but the article does not specify the timeframe for the expected price increase.

The article suggests three health care stocks that may see significant growth in the upcoming quarter. Haemonetics Corporation (HAE) recently reported better-than-expected quarterly earnings, and its stock has seen a decline of around 19% in the past month. Immunitybio Inc (IBRX) recently announced positive results from a study involving the AdHER2DC cancer vaccine and ANKTIVA. Progyny Inc (PGNY) recently reported worse-than-expected second-quarter revenue results. The overall trend for these stocks may be influenced by a variety of factors including the performance of the health care sector, macroeconomic trends, and company-specific news. Investors should conduct their own thorough analysis before making any investment decisions.